The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Helicobacter Pylori Diagnostics Market Research Report 2024
Synopsis
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
The global Helicobacter Pylori Diagnostics market was valued at US$ 638 million in 2023 and is anticipated to reach US$ 1050.8 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.
This report aims to provide a comprehensive presentation of the global market for Helicobacter Pylori Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori Diagnostics.
Report Scope
The Helicobacter Pylori Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Helicobacter Pylori Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Helicobacter Pylori Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept
Segment by Type
Invasive Techniques
Non-invasive Techniques
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Helicobacter Pylori Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
The global Helicobacter Pylori Diagnostics market was valued at US$ 638 million in 2023 and is anticipated to reach US$ 1050.8 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.
This report aims to provide a comprehensive presentation of the global market for Helicobacter Pylori Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori Diagnostics.
Report Scope
The Helicobacter Pylori Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Helicobacter Pylori Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Helicobacter Pylori Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept
Segment by Type
Invasive Techniques
Non-invasive Techniques
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Helicobacter Pylori Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Invasive Techniques
1.2.3 Non-invasive Techniques
1.3 Market by Application
1.3.1 Global Helicobacter Pylori Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Helicobacter Pylori Diagnostics Market Perspective (2019-2030)
2.2 Helicobacter Pylori Diagnostics Growth Trends by Region
2.2.1 Global Helicobacter Pylori Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Helicobacter Pylori Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Helicobacter Pylori Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Helicobacter Pylori Diagnostics Market Dynamics
2.3.1 Helicobacter Pylori Diagnostics Industry Trends
2.3.2 Helicobacter Pylori Diagnostics Market Drivers
2.3.3 Helicobacter Pylori Diagnostics Market Challenges
2.3.4 Helicobacter Pylori Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue
3.1.1 Global Top Helicobacter Pylori Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Helicobacter Pylori Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Helicobacter Pylori Diagnostics Revenue
3.4 Global Helicobacter Pylori Diagnostics Market Concentration Ratio
3.4.1 Global Helicobacter Pylori Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Helicobacter Pylori Diagnostics Revenue in 2023
3.5 Helicobacter Pylori Diagnostics Key Players Head office and Area Served
3.6 Key Players Helicobacter Pylori Diagnostics Product Solution and Service
3.7 Date of Enter into Helicobacter Pylori Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Helicobacter Pylori Diagnostics Breakdown Data by Type
4.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Type (2025-2030)
5 Helicobacter Pylori Diagnostics Breakdown Data by Application
5.1 Global Helicobacter Pylori Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Helicobacter Pylori Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Helicobacter Pylori Diagnostics Market Size (2019-2030)
6.2 North America Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
6.4 North America Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Helicobacter Pylori Diagnostics Market Size (2019-2030)
7.2 Europe Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
7.4 Europe Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Helicobacter Pylori Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Helicobacter Pylori Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Helicobacter Pylori Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Helicobacter Pylori Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Helicobacter Pylori Diagnostics Market Size (2019-2030)
9.2 Latin America Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Helicobacter Pylori Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Helicobacter Pylori Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Helicobacter Pylori Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Helicobacter Pylori Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sekisui Diagnostics
11.1.1 Sekisui Diagnostics Company Detail
11.1.2 Sekisui Diagnostics Business Overview
11.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Introduction
11.1.4 Sekisui Diagnostics Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.1.5 Sekisui Diagnostics Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Medline Industries
11.3.1 Medline Industries Company Detail
11.3.2 Medline Industries Business Overview
11.3.3 Medline Industries Helicobacter Pylori Diagnostics Introduction
11.3.4 Medline Industries Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.3.5 Medline Industries Recent Development
11.4 Meridian Bioscience
11.4.1 Meridian Bioscience Company Detail
11.4.2 Meridian Bioscience Business Overview
11.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Introduction
11.4.4 Meridian Bioscience Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.4.5 Meridian Bioscience Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Introduction
11.5.4 Bio-Rad Laboratories Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Introduction
11.6.4 Thermo Fisher Scientific Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Alpha Laboratories
11.7.1 Alpha Laboratories Company Detail
11.7.2 Alpha Laboratories Business Overview
11.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Introduction
11.7.4 Alpha Laboratories Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.7.5 Alpha Laboratories Recent Development
11.8 EKF Diagnostics
11.8.1 EKF Diagnostics Company Detail
11.8.2 EKF Diagnostics Business Overview
11.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Introduction
11.8.4 EKF Diagnostics Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.8.5 EKF Diagnostics Recent Development
11.9 Quidel
11.9.1 Quidel Company Detail
11.9.2 Quidel Business Overview
11.9.3 Quidel Helicobacter Pylori Diagnostics Introduction
11.9.4 Quidel Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.9.5 Quidel Recent Development
11.10 Halyard Health
11.10.1 Halyard Health Company Detail
11.10.2 Halyard Health Business Overview
11.10.3 Halyard Health Helicobacter Pylori Diagnostics Introduction
11.10.4 Halyard Health Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.10.5 Halyard Health Recent Development
11.11 Cardinal Health
11.11.1 Cardinal Health Company Detail
11.11.2 Cardinal Health Business Overview
11.11.3 Cardinal Health Helicobacter Pylori Diagnostics Introduction
11.11.4 Cardinal Health Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.11.5 Cardinal Health Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Detail
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Introduction
11.12.4 Beckman Coulter Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.12.5 Beckman Coulter Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Detail
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Introduction
11.13.4 Agilent Technologies Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.13.5 Agilent Technologies Recent Development
11.14 Coris BioConcept
11.14.1 Coris BioConcept Company Detail
11.14.2 Coris BioConcept Business Overview
11.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Introduction
11.14.4 Coris BioConcept Revenue in Helicobacter Pylori Diagnostics Business (2019-2024)
11.14.5 Coris BioConcept Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
